Article
MELD 3.0 is a More Equitable and Accurate Predictor of Mortality in Patients with Cirrhosis than MELD-Na
March 1, 2023
Clinical question: How does Model for End-Stage Liver Disease (MELD) 3.0 compare to MELD-Na in regard to liver transplant waitlist mortality? Background: The MELD-Na scoring system has been proven...
![1]()
News
Safety-net burden linked with poorer inpatient cirrhosis outcomes
June 21, 2021
Even so, hospitalizations and mortality were still higher in Black patients than White patients after controlling for hospitals’ safety-net burden.
![1]()
News
Eliminating hepatitis by 2030: HHS releases new strategic plan
January 14, 2021
The United States “is currently facing unprecedented hepatitis A outbreaks, while progress in preventing hepatitis B has stalled, and hepatitis C rates nearly tripled.”
News
Updated USPSTF HBV screening recommendation may be a ‘lost opportunity’
January 12, 2021
The recommendation defines risk groups more narrowly than the CDC, AASLD, and some research suggests risk-based screening is ineffective for chronic conditions.
News
Liver injury linked to COVID-19–related coagulopathy
November 18, 2020
Cells that line the liver’s blood vessels produce high levels of factor VIII, a coagulation factor, when they are exposed to interleukin-6, an inflammatory molecule associated with COVID-19.
![1]()
News
INR fails to predict bleeding in patients with cirrhosis
October 6, 2020
The investigators hope the study findings reinforce minimizing administration of fresh frozen plasma for inappropriate correction of international normalized ratio, which carries a multitude of adverse effects among cirrhotic patients.
![1]()
News
Tools emerging to predict liver failure in cirrhosis
September 9, 2020
Systemic inflammation, with high levels of proteins, is one of the mechanisms that leads to organ failure.
News
NAFLD may predict arrhythmia recurrence post-AFib ablation
August 14, 2020
The presence of nonalcoholic fatty liver disease adds a further modifiable target for preablation medical optimization, researchers say.
News
New CDC guidance for health care personnel exposed to HCV
July 24, 2020
Baseline testing of the source patient and the HCP should be performed as soon as possible, preferably within 48 hours of exposure.
News
Hep C sofosbuvir/daclatasvir combo promising for COVID-19
July 13, 2020
“We need to remember that conducting research amidst a pandemic with overwhelmed hospitals is a clear challenge, and we cannot be sure of success.”
